Clinical Trials in Minneapolis

Showing 4701-4720 of 14,456 trials

Development of Upper Limb Motor Scale to Measure Quality of Movement and Body Awareness in Stroke

NCT03328468

For the breathing intervention, participants completed two experimental sessions at least two weeks apart. The experimental sessions were randomized between the slow-breathing condition (6 breaths/min) or the control breathing condition (12 breaths/min). Breathing interventions were 15 minutes in length and completed with the assistance of the breathing app, Breathe Deep (Mineev, Bizi Apps LLC). The breathing intervention is currently completed. The reliability and validity study of AFAS is ongoing. This is a one-time visit for participants in which participants will undergo screening of sensation and movement as well as fill in some questionnaires.

Stroke

University of Minnesota41 participantsStarted Dec 2017

Minneapolis, Minnesota, United States

COMPLETEDPhase 2< 1 mile

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

NCT03541603

Phase 2 study to evaluate the efficacy and safety of intermittent levosimendan compared with placebo in hemodynamic improvement with exercise in PH-HFpEF subjects

Hypertension Pulmonary SecondaryHeart Failure, Right SidedHeart Failure With Normal Ejection Fraction

Tenax Therapeutics, Inc.44 participantsStarted Nov 2018

Stanford, California, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +13 more locations

Development of Upper Limb Motor Scale to Measure Quality of Movement and Body Awareness in Stroke

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

Find Trials by Condition in Minneapolis

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

Meniscal Root Tears: Evaluation Using an Ultrahigh MRI

Full Vs Partial Weightbearing During the First Six Weeks of Rehab. After Fibular Collateral Ligament Reconstruction

Non- Vs Partial Controlled Weightbearing After Multiple Knee Ligament Reconstruction

Evaluation of a Quality Improvement Project on Impacted Fetal Head at Cesarean Section

Alzheimer's Disease Neuroimaging Initiative 2

Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy

SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

FPA150 in Patients With Advanced Solid Tumors

Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder

Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.

Multidisciplinary Approach for High-risk Patients Leading to Early Diagnosis of Canadians With Heart Failure

Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform Trial